Helpful resources about Glatopa treatment and GlatopaCare
Download these resources to help you start and stay on treatment.
Welcome to Glatopa Patient Manual
For patients new to Glatopa and already enrolled in GlatopaCare, a complete guide to starting Glatopa and how to take advantage of GlatopaCare support services. Brochure is included in the Glatopa Starter Kit.
Glatopaject® Instructions for Use
A step-by-step guide for using the Glatopaject injection device.
Glatopaject FAQ Videos
Address common questions you may have when using your Glatopaject device.
Q. What needle depth should I use?
Q. It seems that my device is not working. What should I do?
Glatopa Patient Information
Glatopa® (glatiramer acetate injection) for Subcutaneous Injection.
Glatopaject Instructions for Use
Provides instructions on how to use your Glatopaject injection device.
Bienvenido al Manual del paciente de Glatopa
Hay una guía completa para comenzar Glatopa y cómo aprovechar los servicios de apoyo de GlatopaCare para pacientes nuevos en Glatopa y para los que ya están inscritos en GlatopaCare. El folleto se incluye en el kit de inicio de Glatopa.
Indication
Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Important Safety Information
Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.
Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your healthcare provider right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your healthcare provider tells you to begin again.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your healthcare provider if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your healthcare provider of any skin changes.
Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.
The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your healthcare provider or pharmacist. Tell your healthcare provider about any side effects you have while taking Glatopa.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information for Glatopa.
